| T1023 | Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter | 2,970 | $250 | $735.6K |
| 90471 | In this procedure, the provider administers a live attenuated vaccine using a percutaneous, intradermal, subcutaneous, or intramuscular route. | 3,200 | $20 | $57.7K |
| T1017 | Targeted case management, each 15 minutes | 760 | $50 | $35.7K |
| 90686 | This code represents a vaccine product administered into the muscle to protect against four strains of influenza (flu). It is preservative free, uses split virus technology, and is given as a 0.5 mL… | 1,690 | $10 | $11.8K |
| 91322 | This code represents a SARS–CoV–2 vaccine product administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 50 mcg/0.5 mL. | 20 | $90 | $1.9K |
| 90472 | This code represents each injection of a vaccine after the first; list this code in addition to the code for the first injection. | 820 | $1 | $1.6K |
| 90651 | This code represents a nonavalent human papillomavirus (HPV) vaccine product administered into the muscle to protect against HPV infection. The vaccine protects against nine HPV types (6, 11, 16, 18,… | 180 | $10 | $1.4K |
| H1004 | Prenatal care, at-risk enhanced service; follow-up home visit | 30 | $50 | $1.3K |
| 90480 | The provider administers the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. | 60 | $20 | $1.3K |
| 90633 | This code represents a vaccine product administered into a muscle to protect against hepatitis A, a liver infection. This code is specific to a pediatric/adolescent dosage with a two–dose schedule. | 40 | $10 | $520 |